| | |
Control group
|
Nutrition group
|
Total
|
P value
|
|---|
|
Agea
| |
59.04 ± 7.61/year
|
57.80 ± 9.70/year
|
58.35 ± 8.8/year
|
0.482
|
|
Sex
|
Male
|
25 (92.6 %)
|
29 (93.5 %)
|
54 (93.1 %)
|
1
|
|
Female
|
2 (7.4 %)
|
2 (6.5 %)
|
4(6.9 %)
| |
|
FEV-1a
| |
74.5 ± 15.01 %
|
71.55 ± 15.52 %
|
72.84 ± 15.23 %
|
0.594
|
|
BMI
|
Thoracotomy
|
26.7 ± 4.20
|
24.0 ± 3.69
|
25.21 ± 4.11
|
0.051
|
|
VATS
|
26.6 ± 2.26
|
27.3 ± 4.19
|
26.92 ± 3.31
|
0.632
|
|
Total
|
26.7 ± 3.49
|
25.2 ± 4.13
|
25.86 ± 3.88
|
0.138
|
|
Operation Type
|
Thoracotomy
|
16 (59.3 %)
|
20 (64.5 %)
|
36 (62.06 %)
|
0.788
|
|
VATS
|
11 (40.7 %)
|
11 (35.5 %)
|
22 (37.94 %)
| |
|
Resection Type
|
LUL
|
5 (18.52 %)
|
9 (29.03 %)
|
14 (24.14 %)
|
0.788
|
|
LLL
|
4 (14.81 %)
|
6 (19.35 %)
|
10 (17.24 %)
| |
|
RLL
|
5 (18.52 %)
|
6 (19.35 %)
|
11 (18.97 %)
| |
|
L-P
|
2 (7.41 %)
|
5 (16.13 %)
|
7 (12.07 %)
| |
|
RUL
|
8 (29.63 %)
|
3 (9.68 %)
|
11 (18.97 %)
| |
|
RSBL
|
2 (7.41 %)
|
2 (6.45 %)
|
4 (6.89 %)
| |
|
RIBL
|
1 (3.7 %)
| |
1 (1.72 %)
| |
|
Drainage Timeb
| |
6 (42–1)/day
|
4 (15–2)/day
|
4.9 ± 2.26/day
|
0.019
|
|
Complication
|
PAL
|
7 (58.33 %)
|
4 (66.67 %)
|
11 (18 %)
| |
|
Atelectasis
|
3 (25 %)
|
1 (16.67 %)
|
4 (6.8 %)
| |
|
Pneumonia
|
1 (8.33 %)
|
1 (16.67 %)
|
2 (3.4 %)
| |
|
Arhytmia
|
1 (8.33 %)
| |
1 (1.7 %)
| |
|
Total
|
12 (44.4 %)
|
6 (19.4 %)
|
18 (31.04 %)
|
0.049
|
| |
AC
|
17 (62.96 %)
|
12 (38.71 %)
|
27 (46.55 %)
|
0.122
|
|
Histology
|
SCC
|
9 (33.33 %)
|
18 (58.06 %)
|
27 (46.55 %)
| |
| |
Carcinoid
|
1 (3.7 %)
|
1 (3.23 %)
|
2 (6.9 %)
| |
|
Stage
|
IA
|
7 (25.93 %)
|
11 (35.48 %)
|
18 (31.04 %)
|
0.608
|
| |
IB
|
6 (22.22 %)
|
3 (9.68 %)
|
9 (15.52 %)
| |
| |
IIA
|
8 (29.63 %)
|
7 (22.58 %)
|
15 (25.86 %)
| |
| |
IIB
|
3 (11.11 %)
|
6 (19.35 %)
|
9 (15.52 %)
| |
| |
IIIA
|
3 (11.11 %)
|
4 (12.9 %)
|
7 (12.06 %)
| |
|
Concomitant Diseases
|
Hypertension
|
4 (44.44 %)
|
5 (38.46 %)
|
9 (40.91 %)
| |
|
COPD
| |
3 (23.08 %)
|
3 (13.64 %)
| |
|
CAD
| |
2 (15.38 %)
|
2 (9.09 %)
| |
|
MNG
|
2 (22.22 %)
|
1 (7.69 %)
|
3 (13.64 %)
| |
|
CHF
| |
1 (7.69 %)
|
1 (4.55 %)
| |
|
Asthma
| |
1 (7.69 %)
|
1 (4.55 %)
| |
|
AS
|
1 (11.11 %)
| |
1 (4.55 %)
| |
|
Parkinson
|
1 (11.11 %)
| |
1 (4.55 %)
| |
|
PVD
|
1 (11.11 %)
| |
1 (4.55 %)
| |
|
Total
|
9 (33.3 %)
|
13 (41.9 %)
|
22 (37.9 %)
|
0.592
|
- Pearson Chi-Square Test (Monte Carlo) - Mann Whitney U Test (Monte Carlo) - Independent T Test (Bootstrap)
-
aMean ± SD, bMedyan Range (Maximum- Minimum), n (%)
- BMI: Body Mass Index; VATS: Video-assisted thoracoscopic surgery; LUL: Left Upper Lobectomy; LLL: Left Lower Lobectomy; RLL: Right Lower Lobectomy; L-P: Left Pneumonectomy; RUL: Right Upper Lobectomy; RSBL: Right Superior Bilobectomy; RIBL: Right İnferior Bilobectomy; PAL: Prolonged Air Leak; AC: Adenocarcinoma; SCC: Squamous Cell Carcinoma; CAD: Coronary Artery Disease; COPD: Chronic obstructive pulmonary disease; MNG: Multinodular goiter; CHF: Congestive heart failure; AS: Ankylosing spondylitis; PVD: Peripheral vessel disease
